Earnings History Data for vTv Therapeutics Inc. (VTVT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
vTv Therapeutics Inc.
vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company's drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-08-2024 | AH | VTVT | vTv Therapeutics Inc. | 40.19 | -0.81 | 0.00 | -2.80 | vTv Therapeutics GAAP EPS of -$0.81 [8/8/2024 6:52 PM] |
13.98 | 0.49 (3.63%) |
0.0 | 0.0 (0.00%) |
7.38 - 31.20 | 1,742 | 50,000 | 0 | ||
| 06-03-2023 | AH | VTVT | vTv Therapeutics | 83.00 | -0.06 | -0.06 | 0.00 | 0.8831 | -0.06 (-6.04%) |
0.88 | -0.06 (-6.39%) |
0.38 - 1.40 | 152,815 | 310,000 | 16,781 | |||
|
|
||||||||||||||||||
| 10-11-2022 | AH | VTVT | vTv Therapeutics | 105.00 | -0.05 | -0.05 | 0.00 | vTv Therapeutics GAAP EPS of -$0.05 [11/10/2022 5:44 PM] |
0.8912 | -0.03 (-3.14%) |
0.85 | -0.07 (-7.62%) |
0.38 - 1.56 | 43,639 | 60,000 | 6,603 | ||
| 15-08-2022 | PM | VTVT | vTv Therapeutics | 113.00 | -0.04 | -0.10 | 0.00 | vTv Therapeutics GAAP EPS of -$0.04 [8/16/2022 3:00 AM] |
1.21 | -0.16 (-11.68%) |
1.35 | -0.02 (-1.46%) |
0.38 - 2.17 | 597,615 | 420,000 | 31,678 | ||
| 12-05-2022 | PM | VTVT | vTv Therapeutics Inc. | 43.22 | -0.10 | -0.08 | -0.09 | vTv Therapeutics GAAP EPS of -$0.10, revenue of $2M [5/12/2022 8:27 AM] |
0.4018 | -0.02 (-4.74%) |
0.42 | 0.0 (-0.40%) |
0.39 - 2.88 | 740,219 | 190,000 | 960 | ||
| 09-11-2021 | PM | Before the open (Nov 9) |
VTVT | vTv Therapeutics | 119.00 | -0.02 | -0.07 | 0.00 | vTv Therapeutics EPS beats by $0.05, beats on revenue [11/9/2021 9:00 AM] |
1.50 | 0.0 (0.00%) |
1.43 | -0.07 (-4.67%) |
1.37 - 4.75 | 1,062,958 | 850,000 | 32,612 | |
|
||||||||||||||||||
| 04-08-2021 | AH | 4:10 PM ET (Aug 4) |
VTVT | Vtv Therapeutics Inc. | 157.00 | -0.01 | -0.07 | 0.00 | vTv Therapeutics reports Q2 results [8/4/2021 5:29 PM] |
1.91 | -0.04 (-2.30%) |
1.92 | -0.04 (-2.04%) |
1.44 - 4.75 | 396,205 | 320,000 | 1,361 | |
| 05-05-2021 | AH | 4:30 PM ET (May 5) |
VTVT | Vtv Therapeutics Inc. | 205.00 | -0.09 | -0.06 | 0.00 | vTv Therapeutics EPS misses by $0.03, beats on revenue [5/5/2021 5:08 PM] |
2.38 | -0.05 (-2.06%) |
2.40 | -0.03 (-1.23%) |
1.44 - 4.75 | 1,223,805 | 910,000 | 4,492 | |
| 24-02-2021 | AH | VTVT | Vtv Therapeutics Inc. | 193.00 | 0.02 | -0.06 | 0.00 | vTv Therapeutics EPS beats by $0.08, beats on revenue [2/24/2021 4:59 PM] |
2.54 | 0.02 (0.59%) |
2.63 | 0.10 (3.95%) |
1.44 - 4.75 | 1,116,952 | 2,751,726 | 76,819 | ||
| 24-02-2021 | AH | VTVT | vTv Therapeutics Inc. | 184.02 | 0.02 | -0.05 | -0.11 | vTv Therapeutics EPS beats by $0.08, beats on revenue [2/24/2021 4:59 PM] |
2.54 | 0.02 (0.59%) |
2.63 | 0.10 (3.95%) |
1.44 - 4.75 | 1,116,952 | 2,751,726 | 76,819 | ||